V797P5279B
Federal Supply Schedule
Overview
Government Description
65VII INVITRO DIAGNOSTICS, REAGENTS, TEST KITS&TEST SETS
Awardee
Awarding / Funding Agency
Pricing
Fixed Price With Economic Price Adjustment
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Multiple Award
Who Can Use
Multiple Agencies
Individual Order Limit
$25,000
Vehicle Ceiling
$265,346,775 (13% Used)
Related Opportunity
None
Analysis Notes
Place of Performance Largest percentage of work under issued task orders completed at: Indianapolis, Indiana 46256 United States.
Amendment Since initial award the Ordering Period End Date was extended from 09/30/16 to 09/30/21.
Subcontracting Plan This FSS has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Amendment Since initial award the Ordering Period End Date was extended from 09/30/16 to 09/30/21.
Subcontracting Plan This FSS has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Roche Diagnostics Corporation was awarded
Federal Supply Schedule V797P5279B V797P5279B
by
VISN 12: Great Lakes Health Care System
for 65Vii Invitro Diagnostics, Reagents, Test Kits&Test Sets
in September 2011.
The FSS
has a duration of 10 years and
was awarded
full & open
with
NAICS 325413 and
PSC 6550
via direct negotiation acquisition procedures with 999 bids received.
To date, $38,430,475 has been obligated through this vehicle with a potential value of all existing task orders of $60,426,193.
The total ceiling is $265,346,775, of which 13% has been used.
As of today, the FSS has a total reported backlog of $25,774,056 and funded backlog of $3,778,338.
Status
(Complete)
Modified 10/19/22
Period of Performance
9/30/11
Start Date
9/30/21
Ordering Period End Date
Task Order Obligations and Backlog
$34.7M
Total Obligated
$38.4M
Current Award
$60.4M
Potential Award
$3.8M
Funded Backlog
$25.8M
Total Backlog
Federal Award Analysis
Historical federal task order obligations under V797P5279B
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Year | Contracts | Subcontracts | Grants | Subgrants |
---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
BPAs
Blanket purchase agreements awarded under V797P5279B
Contract Awards
Prime task orders awarded under V797P5279B
Subcontract Awards
Disclosed subcontracts for V797P5279B
Transaction History
Modifications to V797P5279B
People
Suggested agency contacts for V797P5279B
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
JDMDFEZBYH36
Awardee CAGE
51169
Agency Detail
Awarding Office
36F797 NAC FEDERAL SUPPLY SCHEDULE (36F797)
Funding Office
36F797 NAC FEDERAL SUPPLY SCHEDULE (36F797)
Created By
curtis.brinson@va.gov
Last Modified By
curtis.brinson@va.gov
Approved By
curtis.brinson@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
IN-05
Senators
Todd Young
Mike Braun
Mike Braun
Representative
Victoria Spartz
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Indian Health Services, Indian Health Service, Health and Human Services (075-0390) | Health care services | Supplies and materials (26.0) | $510,959 | 63% |
Defense Health Program, Defense (097-0130) | Department of Defense-Military | Supplies and materials (26.0) | $144,769 | 18% |
Salaries and Expenses, Federal Prison System (015-1060) | Federal correctional activities | Supplies and materials (26.0) | $76,255 | 9% |
Management Fund, National Institutes of Health (075-3966) | Health research and training | Supplies and materials (26.0) | $64,021 | 8% |
Last Modified: 10/19/22